Show
Sort by
-
Multiple sclerosis multidisciplinary care : a national survey and lessons for the global community
-
- Journal Article
- A1
- open access
Identification of DAGLA as an autoantibody target in cerebellar ataxia
-
- Journal Article
- A1
- open access
Utility of icobrain for brain volumetry in multiple sclerosis clinical practice
-
- Journal Article
- A1
- open access
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
-
Routine CSF parameters as predictors of disease course in multiple sclerosis : an MSBase cohort study
-
- Journal Article
- A1
- open access
Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies
-
- Journal Article
- A1
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
-
- Journal Article
- A2
- open access
Machine-learning-based prediction of disability progression in multiple sclerosis : an observational, international, multi-center study
-
- Journal Article
- A1
- open access
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries
-
- Journal Article
- A1
- open access
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation